Medicinal chemistry – Page 39
-
NewsBeetroot beats route to Alzheimer's
Betanin, the compound that gives beetroot it’s distinctive purple colour, may slow the process of protein misfolding that is linked to Alzheimer’s disease
-
Feature3D printing in pharma
Nina Notman explores how 3D printing is carving out a niche for itself in the pharmaceutical industry
-
OpinionWhy combination pills aren’t always the answer
The challenges of medicines containing multiple drugs aren’t going away
-
PodcastTriamcinolone
Concluding our pair of podcasts on a recent cycling scandal, Ben Valsler looks at the corticosteroid triamcinolone
-
ResearchNew theory for why lithium helps bipolar patients
Molecular insight could help researchers design mood stabilisers with fewer side effects
-
NewsChemical weapons watchdog confirms UK’s nerve agent findings
Independent international investigators verify that a Novichok agent was used in attempted assassination of former Russian spy in Salisbury
-
PodcastAcetylcysteine
How a versatile drug that helps manage lung conditions and treat paracetamol overdose found itself at the centre of a cycling scandal
-
BusinessNovartis’ $8.7bn AveXis deal shows gene therapy appeal
Acquisition indicates the value of potentially permanent cures for inherited diseases
-
ResearchArtificial blood reaches the feline frontier
Space crystals of serum proteins help scientists make a red blood cell substitute for cats
-
-
ResearchJelly implant keeps an eye on body oxygen levels
A soft hydrogel implant – the first of which has survived in the foot of its inventor for four years – could detect circulatory problems that end in amputations
-
ResearchSolving the crystal maze
Workflow swaps gut feelings for data when designing continuous crystallisation processes
-
NewsGetting a better grasp of manganese to fight flu
A drug that can hold onto two metals atoms rather than just one becomes 1000 times more potent at knocking out a flu virus enzyme
-
BusinessFit for repurpose
Drugs that can be used for new indications offer a potentially cheaper pathway – but only if the investors can recoup their costs
-
ResearchBacteria churn out a million potential protein drugs
Modified bacteria produce enormous library of macrocycles, one of which inhibits a HIV protein
-
NewsProblems of an ageing population addressed by extra UK funding
£300 million from fund will go towards research on dementia and personalised medicine
-
FeatureCuba: socialism, cigars and biotech
Nina Notman learns how biotechnology could potentially overtake cigars as Cuba’s most famous export
-
ArticleIs industry ready for the serialisation shake-up?
The regulation few outside of pharma have heard about
-
ArticleFive innovative technologies for health
How do healthcare products get from academic or start-up labs to the clinic? With a little help from places like the Centre for Process Innovation
-
ArticleDriving pharmaceutical innovation
Making drugs is neither easy nor cheap – but catalysts, flow chemistry and a knowledge of intermolecular interactions can help